6 Feb

No, IP rights are not the barrier to covid-19 vaccine supplies

Concerns continue to be raised about the role of patents in the coronavirus pandemic response but, argues IAM life sciences reporter Adam Houldsworth, IP has helped more than hindered efforts to inoculate the world’s population

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth